WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
฿5.15
arrow_downward
-0.96%(-0.050) 1ದಿನ
15 ಅಕ್ಟೋ, 03:06:08 PM GMT+7 · THB
search
ಎಲ್ಲಾ ಚಿಹ್ನೆಗಳು
| ಚಿಹ್ನೆ | ಬೆಲೆ | ಬದಲಾವಣೆ | % ಬದಲಾವಣೆ |
|---|
insights_autoWUXI06 ಗಾಗಿ ಉನ್ನತ ಒಳನೋಟಗಳನ್ನು ಜನರೇಟ್ ಮಾಡಲಾಗುತ್ತಿದೆ...
ತೆರೆಯಿರಿ
฿5.25
ಅಧಿಕ
฿5.35
ಕಡಿಮೆ
฿5.15
ಮಾರ್ಕೆಟ್ ಕ್ಯಾಪ್
199.42ಬಿ
ಸರಾಸರಿ ಪ್ರಮಾಣ
93.60ಸಾ
ಪ್ರಮಾಣ
281.24ಸಾ
52 ವಾರದ ಗರಿಷ್ಠ
฿6.25
52 ವಾರದ ಕನಿಷ್ಠ
฿3.02
ಬಾಕಿ ಉಳಿದಿರುವ ಷೇರ್‌ಗಳು
4.12ಬಿ
ಉದ್ಯೋಗಿಗಳ ಸಂಖ್ಯೆ
15ಸಾ
ತೆರೆಯಿರಿ
฿5.25
ಅಧಿಕ
฿5.35
ಕಡಿಮೆ
฿5.15
ಮಾರ್ಕೆಟ್ ಕ್ಯಾಪ್
199.42ಬಿ
ಸರಾಸರಿ ಪ್ರಮಾಣ
93.60ಸಾ
ಪ್ರಮಾಣ
281.24ಸಾ
52 ವಾರದ ಗರಿಷ್ಠ
฿6.25
52 ವಾರದ ಕನಿಷ್ಠ
฿3.02
ಬಾಕಿ ಉಳಿದಿರುವ ಷೇರ್‌ಗಳು
4.12ಬಿ
ಉದ್ಯೋಗಿಗಳ ಸಂಖ್ಯೆ
15ಸಾ
ಸುದ್ದಿ ಸ್ಟೋರಿಗಳು
ವೆಬ್ ಮೂಲಗಳು ಮತ್ತು ಸುದ್ದಿ ಪಾಲುದಾರರಿಂದ
Investing.com
·
4 ನಿಮಿಷಗಳ ಹಿಂದೆ
NYSE short interest hits record high in late September - report
Simply Wall Street
·
48 ನಿಮಿಷಗಳ ಹಿಂದೆ
Why Pegasystems Fell Even As Sales Rose
Stocktwits
·
4 ಗಂಟೆಗಳ ಹಿಂದೆ
SKHY Tracks Worst Month Since Nasdaq Debut: SK Hynix Reportedly Wants To Ship More Chip Tools To China Before Building In US
Investor's Business Daily
·
5 ಗಂಟೆಗಳ ಹಿಂದೆ
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
ಪ್ರೊಫೈಲ್
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics (Cayman) Inc. KKPS DR ಕುರಿತು